Curaleaf Holdings, Inc. (OTC: CURLF)

Curaleaf Holdings, Inc. operates as a leading global cannabis company, delivering a vertically integrated platform with a broad omnichannel distribution footprint. The company serves consumers and patients across the U.S., Canada, Europe, and Australasia. Curaleaf's business model is characterized by its end-to-end supply chain management, which focuses on product quality and consistency. The company's infrastructure includes 17 cultivation sites with approximately 1.5 million square feet of cultivation capacity. Additionally, Curaleaf employs an "asset-light" wholesale and brand-licensing strategy to optimize market exposure and growth opportunities while managing capital allocation strategically.

Curaleaf generates revenue primarily through direct-to-consumer and patient retail sales, as well as wholesale channels. For the year ended December 31, 2025, retail revenues accounted for 73% of total revenues, while wholesale revenues made up 26%. The company's product portfolio includes a diverse range of cannabis products such as flower, pre-rolls, vaporizer cartridges, concentrates, topicals, tinctures, edibles, and beverages. Domestically, these products are marketed under national brands including Anthem, Curaleaf, Find, Grassroots, JAMS, Reef, and Select. Internationally, the company's prominent brands are Curaleaf, Four20, and Huala.

• Domestic Operations: Curaleaf's U.S. operations span 15 states, with 159 retail locations and over 1,300 wholesale partner accounts. The company's domestic footprint includes cultivation sites, manufacturing facilities, and dispensaries across various states. Key brands in this segment include Anthem, Curaleaf, Find, Grassroots, JAMS, Reef, and Select, catering to both medical and adult-use markets.

• International Operations: Curaleaf's international presence is marked by its position as a key wholesaler in emerging medical cannabis markets, including Australasia, Germany, Poland, and the United Kingdom. The company's international brands, Curaleaf, Four20, and Huala, serve these markets, focusing on medical cannabis distribution and wholesale.

Curaleaf operates in a highly competitive cannabis industry, facing competition from a diverse range of legal and illicit operators. In the U.S., competitors range from small, family-owned businesses to multi-state operators (MSOs) with significant market capitalization. Internationally, the company competes with other licensed cultivators and wholesale distributors of medical cannabis. Curaleaf's competitive advantages include its vertically integrated business model, which allows for end-to-end supply chain management and a focus on product quality and consistency. The company's diversified portfolio of brands and products, along with its broad omnichannel distribution footprint, further strengthens its position in the market. Additionally, Curaleaf's investment in research and development, consumer education, and intellectual property protection provides a competitive edge.

Curaleaf's customer base includes both consumers and patients across various markets. The company's products cater to a wide range of cannabis users, from medical patients seeking therapeutic benefits to recreational users looking for adult-use products. The general customer base is diverse, encompassing individuals from different demographics and geographic locations. The company's focus on consumer education and science-backed products aims to build trust and credibility with its customer base, further solidifying its market position.